Related Experiment Video
Updated: Dec 19, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event
Christine Lebrun-Frenay1, Orhun Kantarci2, Aksel Siva3
1Côte d'Azur University, UR2CA, URRIS, CHU de Nice, Pasteur2 Hospital, Nice, France.
Objective:
We have previously identified male sex, younger age, and the presence of spinal cord lesions as independent factors that increase the 5-year risk for evolution from radiologically isolated syndrome (RIS) to multiple sclerosis. Here, we investigate risk factors for the development of a clinical event using a 10-year, multinational, retrospectively identified RIS dataset.
Methods:
RIS subjects were identified according to 2009 RIS criteria and followed longitudinally as part of a worldwide cohort study. We analyzed data from 21 individual databases from 5 different countries. Associations between clinical and magnetic resonance imaging (MRI) characteristics and the risk of developing a first clinical event were determined using multivariate Cox regression models.
Results:
Additional follow-up data were available in 277 of 451 RIS subjects (86% female). The mean age at RIS diagnosis was 37.2 years (range, 11-74 years), with a median clinical follow-up of 6.7 years. The cumulative probability of a first clinical event at 10 years was 51.2%. Age, positive cerebrospinal fluid for oligoclonal bands, infratentorial lesions on MRI, and spinal cord lesions, were baseline independent predictors associated with a subsequent clinical event. The presence of gadolinium-enhanced lesions during follow-up was also associated with the risk of a seminal event. The reason for MRI and gadolinium-enhancing lesions at baseline did not influence the risk of a subsequent clinical event.
Interpretation:
Approximately half of all individuals with RIS experience a first clinical event within 10 years of the index MRI. The identification of independent predictors of risk for symptom onset may guide education and clinical management of individuals with RIS. ANN NEUROL 2020;88:407-417.
More Related Videos
Related Concept Videos
Relative Risk
Biological Effects of Radiation
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Hazard Ratio
For example, in a clinical trial...
Odds Ratio
Aneurysm II: Clinical Manifestations and Diagnostic Studies

